Xuena Li

Prof. Xuena Li


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
SCSong Chen
Song Chen
SHStephanie Harmon
Stephanie Harmon
TPTimothy Perk
Timothy Perk
XLXuena Li
Xuena Li
MCMeijie Chen
Meijie Chen
RJRobert Jeraj
Robert Jeraj
Lung cancer usually presents as a solitary pulmonary nodule (SPN) on diagnostic imaging during the early stages of the disease. Since the early diagnosis of lung cancer is very important for treatment, the accurate diagnosis of SPNs has much importance. The aim of this study was to evaluate the discriminant power of dual time point imaging (DTPI) PET/CT in the differentiation of malignant and benign FDG-avid solitary pulmonary nodules by using neighborhood gray-tone difference matrix (NGTDM) texture features. Retrospective analysis was carried out on 116 patients with SPNs (35 benign and 81 malignant) who had DTPI 18F-FDG PET/CT between January 2005 and May 2015. Both PET and CT images were acquired at 1 h and 3 h after injection. The SUVmax and NGTDM texture features (coarseness, contrast, and busyness) of each nodule were calculated on dual time point images. Patients were randomly divided into training and validation datasets. Receiver operating characteristic (ROC) curve analysis was performed on all texture features in the training dataset to calculate the optimal threshold for differentiating malignant SPNs from benign SPNs. For all the lesions in the testing dataset, two visual interpretation scores were determined by two nuclear medicine physicians based on the PET/CT images with and without reference to the texture features. In the training dataset, the AUCs of delayed busyness, delayed coarseness, early busyness, and early SUVmax were 0.87, 0.85, 0.75 and 0.75, respectively. In the validation dataset, the AUCs of visual interpretations with and without texture features were 0.89 and 0.80, respectively. Compared to SUVmax or visual interpretation, NGTDM texture features derived from DTPI PET/CT images can be used as good predictors of SPN malignancy. Improvement in discriminating benign from malignant nodules using SUVmax and visual interpretation can be achieved by adding busyness extracted from delayed PET/CT images.

18 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YCYan Cui
Yan Cui
YWYuxiang Wang
Yuxiang Wang
SWShu Wang
Shu Wang
BDBulin Du
Bulin Du
XLXuena Li
Xuena Li
YLYa-ming Li
Ya-ming Li
Fibrosis is a common healing process that occurs during stress and injury in cardiovascular diseases. The evolution of fibrosis is associated with cardiovascular disease states and causes adverse effects. Fibroblast activation is responsible for the formation and progression of fibrosis. The incipient detection of activated fibroblasts is important for patient management and prognosis. Fibroblast activation protein (FAP), a membrane-bound serine protease, is almost specifically expressed in activated fibroblasts. The development of targeted FAP-inhibitor (FAPI) positron emission tomography (PET) imaging enabled the visualisation of FAP, that is, incipient fibrosis. Recently, research on FAPI PET imaging in cardiovascular diseases increased and is highly sought. Hence, we comprehensively reviewed the application of FAPI PET imaging in cardiovascular diseases based on the state-of-the-art published research. These studies provided some insights into the value of FAPI PET imaging in the early detection of cardiovascular fibrosis, risk stratification, response evaluation, and prediction of the evolution of left ventricular function. Future studies should be conducted with larger populations and multicentre patterns, especially for response evaluation and outcome prediction.

11 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZCZhiming Cheng
Zhiming Cheng
SWShu Wang
Shu Wang
SXShuoyan Xu
Shuoyan Xu
BDBulin Du
Bulin Du
XLXuena Li
Xuena Li
YLYa-ming Li
Ya-ming Li
FAPI PET/CT is a novel imaging tool targeting fibroblast activation protein (FAP), with high tumor uptake rate and low background noise. Therefore, the appearance of FAPI PET/CT provides a good tumor-to-background ratio between tumor and non-tumor tissues, which is beneficial to staging, tumor description and detection. Colorectal cancer has the biological characteristics of high expression of FAP, which provides the foundation for targeted FAP imaging. FAPI PET/CT may have a potential role in changing the staging and re-staging of colorectal cancer, monitoring recurrence and treatment management, and improving the prognosis of patients. This review will summarize the application status of FAPI PET/CT in colorectal cancer and provide directions for further application research.

1 January 2023 in Journal of Cancer
Verified
Journal Article
Open access
PDF file
ZZZhenzhen Zhang
Zhenzhen Zhang
QLQiu Luan
Qiu Luan
WHWanting Hao
Wanting Hao
YCYan Cui
Yan Cui
YLYaming Li
Yaming Li
XLXuena Li
Xuena Li
Background: NOX4 is highly expressed in breast cancer and is closely associated with cell invasion and metastasis. The involvement of NOX4 in glycolysis in breast cancer remains unclear. The aim of this study was to investigate the role and mechanism of NOX4 in glycolysis in breast cancer.

1 October 2016 in European Journal of Radiology
Verified
Journal Article
Open access
SCSong Chen
Song Chen
XLXuena Li
Xuena Li
MCMeijie Chen
Meijie Chen
YYYafu Yin
Yafu Yin
NLNa Li
Na Li
YLYa-ming Li
Ya-ming Li
This study is aimed to compare the diagnostic power of using quantitative analysis or visual analysis with single time point imaging (STPI) PET/CT and dual time point imaging (DTPI) PET/CT for the classification of solitary pulmonary nodules (SPN) lesions in granuloma-endemic regions. SPN patients who received early and delayed (18)F-FDG PET/CT at 60min and 180min post-injection were retrospectively reviewed. Diagnoses are confirmed by pathological results or follow-ups. Three quantitative metrics, early SUVmax, delayed SUVmax and retention index(the percentage changes between the early SUVmax and delayed SUVmax), were measured for each lesion. Three 5-point scale score was given by blinded interpretations performed by physicians based on STPI PET/CT images, DTPI PET/CT images and CT images, respectively. ROC analysis was performed on three quantitative metrics and three visual interpretation scores. One-hundred-forty-nine patients were retrospectively included. The areas under curve (AUC) of the ROC curves of early SUVmax, delayed SUVmax, RI, STPI PET/CT score, DTPI PET/CT score and CT score are 0.73, 0.74, 0.61, 0.77 0.75 and 0.76, respectively. There were no significant differences between the AUCs in visual interpretation of STPI PET/CT images and DTPI PET/CT images, nor in early SUVmax and delayed SUVmax. The differences of sensitivity, specificity and accuracy between STPI PET/CT and DTPI PET/CT were not significantly different in either quantitative analysis or visual interpretation. In granuloma-endemic regions, DTPI PET/CT did not offer significant improvement over STPI PET/CT in differentiating malignant SPNs in both quantitative analysis and visual interpretation.

12 July 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JZJiani Zhang
Jiani Zhang
BDBulin Du
Bulin Du
YWYuxiang Wang
Yuxiang Wang
YCYan Cui
Yan Cui
SWShu Wang
Shu Wang
XLXuena Li
Xuena Li
Currently, immunotherapy is being widely used for treating cancers. However, the significant heterogeneity in patient responses is a major challenge for its successful application. CD8-positive T cells (CD8+ T cells) play a critical role in immunotherapy. Both their infiltration and functional status in tumors contribute to treatment outcomes. Therefore, accurate monitoring of CD8+ T cells, a potential biomarker, may improve therapeutic strategy. Positron emission tomography (PET) is an optimal option which can provide molecular imaging with enhanced specificity. This review summarizes the mechanism of action of CD8+ T cells in immunotherapy, and highlights the recent advancements in PET-based tracers that can visualize CD8+ T cells and discusses their clinical applications to elucidate their potential role in cancer immunotherapy.